America, We Have A Drug Problem!
It’s time to do something about it. UAEM is leading a new, fast-paced campaign targeting the National Institutes of Health (NIH) and other government funders of biomedical research and development (R&D) in order to make medicines affordable for all globally. We are building a countrywide movement to leverage public funding for biomedical innovation to make sure that the fruits of the research conducted at our universities is accessible to all in low- and middle-income countries, and available affordably in the United States. No one should be sick because they are poor, or poor because they are sick!
The goal: To begin with, we will aim to urge the NIH to reform its practices to support access to medicine and public health, including placing new conditions on taxpayer-funded research grants that require global access licensing for low- and middle-income countries and affordable pricing requirements in the U.S. None of this requires a change in the law!
For more information refer to our Campaign Brief. If enough of us act quickly, we can win this.
Up to half of all new medicines are invented at universities, funded by taxpayer dollars from government research grants. These life-saving drugs, funded by the public, are then licensed to private pharmaceutical corporations, who sell them back to us at exorbitant prices, often making treatment out of reach altogether. It doesn’t have to be this way. TThe NIH can, with the stroke of a pen, balance out a system that currently denies life-saving medications for millions of patients in the U.S. and millions more worldwide. It is up to us to ensure that our government does the right thing to make medicines funded by the public actually reach the people who need them. Please sign our academic letter and help us take back our meds!
Take Back Our Meds Campaign
UAEM, ACT UP and other social activist groups on July 23, 2016, staged a tug-of-war with pharmabro’s (male pharmaceutical official) outside Hillary Clinton’s Philadelphia campaign headquarters ahead of the Democratic National Convention.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.